1. Home
  2. STKS vs ICCC Comparison

STKS vs ICCC Comparison

Compare STKS & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The ONE Group Hospitality Inc.

STKS

The ONE Group Hospitality Inc.

N/A

Current Price

$1.86

Market Cap

63.3M

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$9.53

Market Cap

75.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STKS
ICCC
Founded
2004
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
75.8M
IPO Year
2011
1995

Fundamental Metrics

Financial Performance
Metric
STKS
ICCC
Price
$1.86
$9.53
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$4.70
N/A
AVG Volume (30 Days)
23.0K
26.7K
Earning Date
05-04-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.85
EPS
N/A
0.21
Revenue
$805,722,000.00
$26,493,169.00
Revenue This Year
$7.47
N/A
Revenue Next Year
$8.12
N/A
P/E Ratio
N/A
$46.10
Revenue Growth
19.66
51.64
52 Week Low
$1.65
$4.52
52 Week High
$5.19
$10.75

Technical Indicators

Market Signals
Indicator
STKS
ICCC
Relative Strength Index (RSI) 51.76 54.79
Support Level $1.89 $9.29
Resistance Level $2.06 $10.75
Average True Range (ATR) 0.12 0.46
MACD -0.01 -0.11
Stochastic Oscillator 49.12 27.40

Price Performance

Historical Comparison
STKS
ICCC

About STKS The ONE Group Hospitality Inc.

The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through three segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: